IBOV 185,147.15 ▼ 0.02% IPSA 11,315.26 ▼ 1.14% IPC MEX 64,866.61 ▼ 0.87% MERVAL 3,049,121 ▼ 0.29% COLCAP 2,544.56 ▲ 0.40% BVL PERÚ 59,978.22 ▼ 0.31% USD/BRL5.13▼ 0.03% USD/MXN16.91▲ 0.21% USD/CLP931.66▼ 0.31% USD/COP3,130▲ 0.01% USD/PEN3.36▲ 0.05% USD/ARS1,500▼ 0.58% USD/UYU40.24— 0.00% USD/PYG5,947— 0.00% USD/BOB12.40— 0.00% USD/DOP58.99▼ 0.02% USD/CRC448.67— 0.00% USD/GTQ7.63— 0.00% USD/HNL26.84— 0.00% USD/NIO36.62— 0.00% USD/VES811.71▲ 0.66% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.71— 0.00% EUR/BRL5.96▲ 0.14% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 185,147.15 ▼ 0.02% IPSA 11,315.26 ▼ 1.14% IPC MEX 64,866.61 ▼ 0.87% MERVAL 3,049,121 ▼ 0.29% COLCAP 2,544.56 ▲ 0.40% BVL PERÚ 59,978.22 ▼ 0.31% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Monday, September 7, 2026

Louisiana nurse blows the whistle: “We are sacrificing our children for fear of maybe dying of a virus with a 99% survival rate”

By · January 2, 2022 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – Collette Martin, a practicing nurse of seventeen years, spoke at a Louisiana Health & Welfare hearing earlier this month about what she has seen in the hospital system during the COVID pandemic.

Collette says she and her colleagues have witnessed “terrifying” reactions to the COVID shots, but their concerns about the vaccines are being ignored and dismissed.

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

Collete went on to say that vaccine-injury report databases like VAERS are so little used that most doctors and nurses don’t even know that it exists, let alone how to file a report.

“The Majority of our nurses, nurse managers, and some doctors do not even know what VAERS is. I’ve spoken to our chief medicine managers and other nurses on why we’re not reporting to VAERS, and the most common response is: “What is VAERS?”

As if this were not bad enough already, she then said that none of the hospitals are reporting any data, meaning that even if someone were investigating, there would be no data to investigate.

“This is not just where I work. I know many nurses, friends, and other local hospitals in Southeast Louisiana that say the same thing.”

However, what she says about the potential long-term effects of the jabs is shocking.

“We are not just seeing severe acute [short term] reactions with this vaccine, but we have zero ideas what any long term reactions are. Cancers, autoimmune [disorders], infertility. We just don’t know.”

“We are potentially sacrificing our children for fear of maybe dying, getting sick of a virus, a virus with a 99% survival rate.”

Collete concludes by saying that these vaccine side-effects are being covered up as caused by the new variant.

“As of now, we have more children that died from the COVID vaccine than COVID itself. And then for the Health Department to come out and say the new variant has all the side effects of the vaccine reactions we’re currently seeing now.

It’s maddening, and I don’t understand why more people don’t see it. I think they do, but they fear speaking out and, even worse, being fired.”

SHOCKING VAERS DATA

VAERS data released December 17 by the Centers for Disease Control and Prevention (CDC) included a total of 965,843 adverse event reports in all age groups following COVID vaccines, including 20,244 deaths and 155,506 serious injuries between December 14, 2020, and December 10, 2021.

U.S. VAERS data  for children aged 5 to 11 years show:

The second death (VAERS ID 1890705 ) occurred in a 5-year-old girl who died four days after her first Pfizer injection.

With information from the COVID World

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.